Nebenwirkungen · Controloc Control
CONTROLOC Control 20 mg gastro-resistant tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-121794 · Präparat HOS-095429
System organ class Eye disorders Disturbances in vision / blurred vision Gastrointestinal Fundic gland Diarrhoea, Microscopic colitis disorders polyps Nausea / (benign) vomiting, Abdominal distension and bloating, Constipation, Dry mouth, Abdominal pain and discomfort Hepatobiliary Liver enzymes Bilirubin Hepatocellular injury, disorders increased increased Jaundice, (transaminases, Hepatocellular failure γ-GT) Skin and Rash / exanthema Urticaria, Stevens-Johnson subcutaneous / eruption, Angioedema syndrome, tissue disorders Pruritus Lyell syndrome (TEN), Drug reaction with eosinophilia and systemic symptoms (DRESS), Erythema multiforme, Photosensitivity, Subacute cutaneous lupus erythematosus (see section 4.4). Musculoskeletal Fracture of wrist, Arthralgia; and connective hip and spine. Myalgia tissue disorders Renal and Tubulointerstitial urinary disorders nephritis (TIN) (with possible progression to renal failure) Reproductive Gynaecomastia system and breast disorders General Asthenia, fatigue Body temperature disorders and and malaise increased; administration Oedema site conditions peripheral (1) Hypocalcaemia and/or hypokalaemia may be related to the occurrence of hypomagnesaemia (see section 4.4)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-05-25T09:08:00Z · SHA-256 e7bfcc80e0d744a3ae6dc7e45d026433d68d865a95e0e5185c1771cd63eb461e · Passage 7bf1a1fca2505d26cce5534f14ffdb544626b942d1627dcac5292764ec1f7f03 · Zeichen 3119–7229 im Abschnitt